Sign up
Quantellect · Congress · Trade Detail
MRTXMirati Therapeutics, Inc. (MRTX) [ST]
DemocratHouse

Daniel S. Goldman sold Mirati Therapeutics, Inc. (MRTX) [ST] (MRTX)

Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 2 trades in Mirati Therapeutics, Inc. (MRTX) [ST] (MRTX) since 2023, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Mirati Therapeutics, Inc. (MRTX) [ST] (MRTX) on April 10, 2023. Since that trade, MRTX is up +0.00% against the S&P 500 up +88.17%, an outperformance of -88.17%.

Across these filings, Daniel S. Goldman has been a balanced trader of MRTX (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Tracked by Quantellect from public STOCK Act disclosures.

Data updated

MRTX trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2023

Daniel S. Goldman's MRTX trades vs the price

MRTX is up +0.00% since Daniel S. Goldman sold on April 10, 2023, versus +88.17% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+88.17%
Outperformance vs S&P 500
-88.17%

All Daniel S. Goldman MRTX trades

TradedTypeSizeReturnEst. profit
April 10, 2023SELL$1,001 - $15,000N/A—
March 6, 2023BUY$1,001 - $15,000N/A—

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Free BullishWhales account
Track Congress across your whole watchlist, not just one stock.
Get a filing alert the moment a member of Congress discloses a trade, plus the full 5-year history and Tide scores on 4,500+ tickers.
Sign up free

Daniel S. Goldman & MRTX trading FAQ

Is it legal for Daniel S. Goldman to trade Mirati Therapeutics, Inc. (MRTX) [ST] (MRTX) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Mirati Therapeutics, Inc. (MRTX) [ST] (MRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Daniel S. Goldman sell MRTX?

Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Mirati Therapeutics, Inc. (MRTX) [ST] (MRTX) on April 10, 2023, according to public STOCK Act filings.

How has MRTX performed since Daniel S. Goldman's trade?

Since Daniel S. Goldman sold MRTX on April 10, 2023, the stock is up +0.00%, versus +88.17% for the S&P 500 over the same period, an outperformance of -88.17%.

How many times has Daniel S. Goldman traded MRTX?

Daniel S. Goldman has disclosed 2 MRTX trades since 2023 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional MRTX trades?

Quantellect tracks every disclosed congressional trade in Mirati Therapeutics, Inc. (MRTX) [ST] (MRTX) on the Mirati Therapeutics, Inc. (MRTX) [ST] congressional trading page, which aggregates filings across all members of Congress.

Daniel S. Goldman's MRTX tradesAll congressional filings for Mirati Therapeutics, Inc. (MRTX) [ST]Daniel S. Goldman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.